Researchers from the University of Liège and international collaborators developed a "virtual clinical trial" exploring a unique pharmacological treatment in patients who do not fully regain consciousness after a coma. The ...
Nov 24, 2025
0
50
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point where they rarely leave their home and are unable to work and build meaningful relationships. Standard ...
Oct 6, 2025
0
24
A single dose of LSD eased anxiety symptoms for many folks and the benefits lasted up to three months, a new study reports.
Sep 5, 2025
2
86
A new study has revealed large differences in attitudes toward various types of drugs, with a growing acceptance of psychedelics and strong negative feelings toward more traditional illicit drugs.
Jun 16, 2025
0
13
The human brain, like the brain of other mammals, is known to start developing before birth, via a coordinated sequence of molecular and cellular processes. Neuroscience studies have found that the choroid plexus (ChP), a ...
A new study conducted by researchers from Reichman University and other Israeli institutions explored the psychological aftermath of the deadly terrorist attack at the Nova Festival in southern Israel. The attack, which took ...
Jun 4, 2025
0
21
Once stigmatized and outlawed, psychedelics are moving from the counterculture to the mainstream. From Prince Harry's use of psilocybin to National Football League quarterback Aaron Rodgers' adventures with ayahuasca, our ...
May 19, 2025
0
16
Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and depression. Some claim the practice ...
Apr 17, 2025
0
22
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.
Apr 14, 2025
1
49
Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent years as a potential method for alleviating symptoms of attention-deficit/hyperactivity disorder ...
